64 related articles for article (PubMed ID: 20024956)
1. Metabolism of the mesoionic compound (MI-D) by mouse liver microsome, detection of its metabolite in vivo, and acute toxicity in mice.
Romão S; Cadena SM; Amorim JC; Méndez-Sánchez SC; Echevarria A; Silva EF; Rocha ME; Noleto GR; Carnieri EG; Martinez GR; Oliveira MB
J Biochem Mol Toxicol; 2009; 23(6):394-405. PubMed ID: 20024956
[TBL] [Abstract][Full Text] [Related]
2. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
3. Interference of MI-D, a new mesoionic compound, on artificial and native membranes.
Cadena SM; Carnieri EG; Echevarria A; de Oliveira MB
Cell Biochem Funct; 2002 Mar; 20(1):31-7. PubMed ID: 11835268
[TBL] [Abstract][Full Text] [Related]
4. Toremifene metabolism in rat, mouse and human liver microsomes: identification of alpha-hydroxytoremifene by LC-MS.
Jones RM; Lim CK
Biomed Chromatogr; 2002 Aug; 16(5):361-3. PubMed ID: 12210510
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
[TBL] [Abstract][Full Text] [Related]
6. Study of phenformin metabolism in rat liver microsomes by HPLC, CE and on-line HPLC-electrospray ionization mass spectrometry.
Llambias EB; Luo J
Biomed Chromatogr; 1996; 10(4):155-60. PubMed ID: 8831958
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of BYZX in human liver microsomes and the structural elucidation of metabolite by liquid chromatography-mass spectrometry method.
Xia ZL; Ying JY; Sheng R; Zeng S; Hu YZ; Yao TW
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):266-74. PubMed ID: 17709305
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic kinetic of puerarin in beagle liver microsomal by HPLC-ESI-MS].
Wen BY; Li H; Wang L; Wang SC
Zhongguo Zhong Yao Za Zhi; 2008 Dec; 33(23):2834-7. PubMed ID: 19260325
[TBL] [Abstract][Full Text] [Related]
9. Determination of 13-O-demethyl tacrolimus in human liver microsomal incubates using liquid chromatography-mass spectrometric assay (LC-MS).
Feng Y; Zhang S; Poloyac S; Strom S; Venkataramanan R
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(1):31-7. PubMed ID: 15897019
[TBL] [Abstract][Full Text] [Related]
10. Effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on B16-F10 murine melanoma.
Senff-Ribeiro A; Echevarria A; Silva EF; Sanches Veiga S; Oliveira MB
Melanoma Res; 2003 Oct; 13(5):465-71. PubMed ID: 14512788
[TBL] [Abstract][Full Text] [Related]
11. Metabolic stability and determination of cytochrome P450 isoenzymes' contribution to the metabolism of medetomidine in dog liver microsomes.
Duhamel MC; Troncy E; Beaudry F
Biomed Chromatogr; 2010 Aug; 24(8):868-77. PubMed ID: 20020418
[TBL] [Abstract][Full Text] [Related]
12. Selective metabolism of E-3,4-bis(4-ethylphenyl)hex-3-ene in rat liver microsomes.
Fabian EJ; Metzler M
Arch Toxicol; 2006 Jan; 80(1):17-26. PubMed ID: 16187102
[TBL] [Abstract][Full Text] [Related]
13. Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability.
Moreno L; Alvarez L; Mottier L; Virkel G; Bruni SS; Lanusse C
J Vet Pharmacol Ther; 2004 Oct; 27(5):299-308. PubMed ID: 15500567
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of the new liposomal anticancer drug N4-octadecyl-1-beta-D-arabinofuranosylcytosine in mice.
Koller-Lucae SK; Suter MJ; Rentsch KM; Schott H; Schwendener RA
Drug Metab Dispos; 1999 Mar; 27(3):342-50. PubMed ID: 10064564
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification.
Kumar GN; Jayanti V; Lee RD; Whittern DN; Uchic J; Thomas S; Johnson P; Grabowski B; Sham H; Betebenner D; Kempf DJ; Denissen JF
Drug Metab Dispos; 1999 Jan; 27(1):86-91. PubMed ID: 9884314
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of N-Phenyl-2-naphthylamine (CAS No. 135-88-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1988 Jan; 333():1-168. PubMed ID: 12732903
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic-fluorescent method to determine chloroacetaldehyde, a neurotoxic metabolite of the anticancer drug ifosfamide, in plasma and in liver microsomal incubations.
Huang Z; Waxman DJ
Anal Biochem; 1999 Aug; 273(1):117-25. PubMed ID: 10452807
[TBL] [Abstract][Full Text] [Related]
19. The identification of in vitro metabolites of CKD-732 by liquid chromatography/tandem mass spectrometry.
Myung SW; Kim HY; Min HK; Kim DH; Kim M; Cho HW; Lee HS; Kim JK; Hong CI
Rapid Commun Mass Spectrom; 2002; 16(21):2048-53. PubMed ID: 12391579
[TBL] [Abstract][Full Text] [Related]
20. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
Zhou S; Paxton JW; Tingle MD; Kestell P
Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
